WuXi AppTec Co., Ltd. (HKG: 2359)

Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
56.05
+0.65 (1.17%)
Nov 7, 2024, 11:06 AM HKT
-41.09%
Market Cap 176.16B
Revenue (ttm) 42.65B
Net Income (ttm) 8.93B
Shares Out n/a
EPS (ttm) 3.04
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date Jun 17, 2024
Volume 4,522,070
Open 53.65
Previous Close 55.40
Day's Range 53.65 - 57.00
52-Week Range 27.50 - 99.55
Beta n/a
Analysts n/a
Price Target n/a
Earnings Date Mar 19, 2025

About WuXi AppTec

WuXi AppTec Co., Ltd., an investment holding company, provides research and manufacturing services to discover, develop, and manufacture spectrum for small molecule drugs and advanced therapies in the People’s Republic of China, the United States, Europe, and internationally. The company operates in six segments: WuXi Chemistry, WuXi Testing, WuXi Biology, WuXi ATU, WuXi DDSU, and Others. It offers contract research, development, and manufacturing organization services for new drug development from discovery to commercial covering various categ... [Read more]

Sector Healthcare
Founded 2000
Employees 41,116
Stock Exchange Hong Kong Stock Exchange
Ticker Symbol 2359
Full Company Profile

Financial Performance

In 2023, WuXi AppTec's revenue was 40.34 billion, an increase of 2.51% compared to the previous year's 39.35 billion. Earnings were 9.61 billion, an increase of 9.00%.

Financial numbers in CNY Financial Statements

News

There is no news available yet.